Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge




leisure time

author：knowledge    Page View：7986
virtual appointment
Adobe

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. 

FDA approves device to save limbs of vascular disease patients

advertisement

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'
Next article： Wildfire smoke exposes gaps in outdoor worker protections